Gastroenterology Market By Product Type (Endoscopes; Endoscopic Ultrasound [EUS] Devices; Laparoscopes; Capsule Endoscopy Devices; Hemostasis Devices; Biopsy Forceps; Stents; Others); By Disease Type (Gastroesophageal Reflux Disease [GERD]; Inflammatory Bowel Disease [IBD]; Irritable Bowel Syndrome [IBS]; Colorectal Cancer; Peptic Ulcer Disease; Liver Diseases; Others); By Procedure Type (Endoscopy; Colonoscopy; Laparoscopy; Esophagogastroduodenoscopy [EGD]; Enteroscopy; Sigmoidoscopy; Others); By End-User (Hospitals; Ambulatory Surgical Centers [ASCs]; Specialty Clinics; Diagnostic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Gastroenterology Market Size & Overview

The gastroenterology market was valued at approximately $36.3 billion in 2024 and is projected to reach $52.1 billion by 2030, growing at a CAGR of 6.2% during the forecast period. The market is primarily driven by the rising prevalence of gastrointestinal (GI) diseases, including colorectal cancer, gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and peptic ulcers.

 

Increasing awareness about preventive healthcare, advancements in diagnostic and therapeutic endoscopy & the growing adoption of minimally invasive procedures are fueling market growth. Additionally, the expansion of AI-assisted diagnostics, robotic-assisted surgeries & capsule endoscopy technologies is enhancing early disease detection and improving patient outcomes. The growing geriatric population, which is more prone to digestive disorders, coupled with rising healthcare expenditures in emerging markets, is further contributing to market expansion. However, challenges such as the high cost of advanced procedures & a shortage of trained gastroenterologists may hinder widespread adoption. Despite these challenges, the arket is expected to witness strong growth due to ongoing technological innovations, increasing demand for personalized treatment approaches & the expansion of specialized gastroenterology healthcare facilities worldwide.

 

Gastroenterology Market Dynamics:

Market Drivers

Rising Prevalence of Gastrointestinal Disorders

The increasing incidence of gastrointestinal (GI) diseases such as colorectal cancer, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD) & peptic ulcers is a major driver of the gastroenterology market. According to the Centers for Disease Control & Prevention (CDC), around 3.1 million adults in the U.S. were diagnosed with IBD (including Crohn’s disease and ulcerative colitis) in 2023, a number that continues to rise. Additionally, GERD affects approximately 20% of the U.S. population, driving demand for endoscopic procedures, proton pump inhibitors (PPIs) & advanced therapeutic interventions. This increasing disease burden is propelling the adoption of endoscopic procedures, GI biologics, and minimally invasive surgeries, further expanding the gastroenterology market.

Technological Advancements in Gastrointestinal Diagnostics & Treatment

Innovations in endoscopic technology, capsule endoscopy, artificial intelligence (AI)-powered diagnostics & robotic-assisted surgeries are significantly enhancing the detection and treatment of GI disorders. For example, AI-based endoscopic systems like Medtronic’s GI Genius™ intelligent endoscopy module have improved polyp detection rates during colonoscopy screenings by 14%, leading to earlier diagnosis and better patient outcomes. Additionally, robot-assisted surgeries for gastrointestinal conditions, such as Da Vinci Surgical System by Intuitive Surgical, have gained traction due to their precision & reduced recovery time. These technological advancements are increasing procedure volumes & improving patient outcomes, driving market growth.

 

Market Opportunities

Growing Demand for Non-Invasive & Minimally Invasive Procedures

The demand for minimally invasive gastroenterology procedures, such as endoscopic submucosal dissection (ESD), endoscopic ultrasound (EUS), and transoral incisionless fundoplication (TIF) for GERD treatment, is on the rise. These procedures offer reduced hospital stays, lower risk of complications & faster recovery times compared to traditional open surgeries. The global minimally invasive surgery market is expected to grow at a CAGR of over 8.5%, with gastroenterology being a key segment driving this expansion. As patients and healthcare providers prioritize less invasive and more cost-effective solutions, there is a significant opportunity for medical device manufacturers, endoscopy centers, and hospitals to invest in advanced technologies that cater to this demand.

Expanding Geriatric Population and Rising Healthcare Expenditure

The aging population is a major factor contributing to the growth of the gastroenterology market. The World Health Organization (WHO) estimates that by 2050, the global population aged 60 & above will reach 2.1 billion, significantly increasing the prevalence of GI disorders such as colorectal cancer, diverticulosis & dyspepsia. Older adults are more prone to digestive system diseases, requiring frequent diagnostic procedures like colonoscopy & endoscopy. Additionally, rising healthcare expenditures, particularly in emerging markets such as India & China, are boosting investments in gastroenterology-focused healthcare infrastructure, offering lucrative opportunities for market players.

 

Market Restraints

High Cost of Advanced Gastroenterology Procedures and Devices

Despite the benefits of minimally invasive and AI-assisted gastroenterology technologies, the high cost of advanced endoscopic equipment, robotic-assisted surgical systems, and capsule endoscopy devices remains a significant barrier. A single-use capsule endoscopy device can cost between $500 - $1,000 per procedure, limiting its widespread adoption in lower-income regions. Additionally, robotic-assisted surgeries for GI conditions can cost up to $10,000 per procedure, making them inaccessible for many patients & healthcare facilities. The high capital investment required for advanced endoscopy systems, coupled with limited reimbursement policies in certain countries, poses a challenge for market growth.

Shortage of Skilled Gastroenterologists & Endoscopy Specialists

The increasing demand for gastroenterology procedures is being met with a global shortage of trained gastroenterologists & endoscopic specialists. According to the American College of Gastroenterology (ACG), the U.S. faces a growing gap in gastroenterology specialists, with only 14,000 board-certified gastroenterologists serving a population of over 330 million people. This shortage leads to longer wait times for diagnostic & therapeutic procedures, delaying treatment for conditions such as colorectal cancer & inflammatory bowel disease. The lack of trained professionals also restricts the widespread adoption of new endoscopic and robotic technologies, as healthcare providers struggle to keep up with evolving advancements.

 

Gastroenterology Market Segmentation: A Comprehensive Overview

By Product Type

• Endoscopes

• Endoscopic Ultrasound (EUS) Devices

• Laparoscopes

• Capsule Endoscopy Devices

• Hemostasis Devices

• Biopsy Forceps

• Stents

• Others

 

By Disease Type

• Gastroesophageal Reflux Disease (GERD)

• Inflammatory Bowel Disease (IBD)

• Irritable Bowel Syndrome (IBS)

• Colorectal Cancer

• Peptic Ulcer Disease

• Liver Diseases

• Others

 

By Procedure Type

• Endoscopy

• Colonoscopy

• Laparoscopy

• Esophagogastroduodenoscopy (EGD)

• Enteroscopy

• Sigmoidoscopy

• Others

 

By End-User

• Hospitals

• Ambulatory Surgical Centers (ASCs)

• Specialty Clinics

• Diagnostic Centers

 

By Region

• North America

• Europe

• Asia-Pacific

• Latin America

• Middle East & Africa

 

Gastroenterology Market Segment Analysis: Growth Trends Across Categories

By Product Type:

Leading Segment: Endoscopes

Endoscopes hold the largest market share in the gastroenterology market, accounting for around 35% of the total market share. This dominance is driven by their widespread use in a variety of diagnostic & therapeutic procedures across different gastrointestinal conditions. Endoscopes are critical in the visualization and diagnosis of diseases like colorectal cancer, inflammatory bowel disease (IBD), and gastrointestinal reflux disease (GERD). As the demand for minimally invasive diagnostic procedures increases, the market for endoscopes continues to grow. The global market for endoscopes is projected to grow at a CAGR of 5.5% in the next five years.

Fastest-Growing Segment: Capsule Endoscopy Devices

Capsule endoscopy devices are the fastest-growing segment in the gastroenterology market, with a CAGR of 9.2%. These devices provide non-invasive, high-resolution imaging of the gastrointestinal tract, especially for small intestine exploration. As technology advances, the ease of use, accuracy & reduced patient discomfort have driven the increasing adoption of capsule endoscopy devices. This growth is further supported by the rise in gastrointestinal disorders & the demand for more efficient diagnostic methods.

 

By Disease Type:

Leading Segment: Gastroesophageal Reflux Disease (GERD)

GERD remains the leading disease type in the gastroenterology market, accounting for 28% of the total market share. GERD is prevalent across all age groups, particularly among older populations & those with sedentary lifestyles. With an increasing global burden of chronic diseases, the need for effective diagnosis and management of GERD continues to grow, driving market demand for gastroenterology devices and procedures. The market for GERD treatment is expected to grow steadily, contributing significantly to the overall market expansion.

Fastest-Growing Segment: Colorectal Cancer

Colorectal cancer is the fastest-growing disease type in the gastroenterology market, with a CAGR of 7.6%. This is due to rising awareness about early detection and screening, especially in high-risk populations. As a leading cause of cancer-related deaths globally, colorectal cancer is driving innovations in diagnostic tools such as colonoscopes and biopsy forceps. The adoption of screening methods for early detection and preventive care has contributed to the surge in demand for related gastroenterology products.

 

By Procedure Type:

Leading Segment: Endoscopy

The endoscopy procedure segment holds the largest share of the gastroenterology market, contributing around 40% to the total market. Endoscopy is a widely used procedure for diagnosing and treating gastrointestinal conditions such as GERD, IBD, and colorectal cancer. Its minimally invasive nature makes it a preferred method in many hospitals and ambulatory surgical centers (ASCs). The demand for endoscopy procedures is expected to continue growing due to the increasing prevalence of gastrointestinal disorders and the push for less invasive treatments.

Fastest-Growing Segment: Colonoscopy

Colonoscopy is the fastest-growing procedure type, with a CAGR of 6.8%. This procedure is gaining traction due to its critical role in colorectal cancer prevention and early detection. Increased awareness about colorectal cancer screening, particularly in older populations, has contributed to this growth. Additionally, advancements in colonoscopy technology & improved patient comfort have further boosted the demand for this procedure.

 

By End-User:

Leading Segment: Hospitals

Hospitals remain the largest end-user in the gastroenterology market, accounting for around 45% of the total market share. This dominance is due to the large volume of gastrointestinal procedures conducted in hospitals, ranging from diagnostic endoscopies to surgical treatments for conditions like IBD and colorectal cancer. Hospitals are equipped with advanced gastroenterology devices and offer comprehensive care, including preoperative and postoperative management, driving the large share.

Fastest-Growing Segment: Ambulatory Surgical Centers (ASCs)

Ambulatory surgical centers (ASCs) are the fastest-growing end-user segment, with a CAGR of 8.3%. The rising preference for outpatient surgical procedures due to reduced hospital stays, lower costs & convenience has driven the growth of ASCs in the gastroenterology market. ASCs offer a wide range of gastroenterology services, including endoscopic procedures, making them an attractive option for both patients & healthcare providers.

 

By Region:

Leading Region: North America

North America holds the largest market share in the gastroenterology market, contributing around 38% of the global market. The dominance of North America is driven by the high prevalence of gastrointestinal disorders, well-established healthcare infrastructure & the growing adoption of advanced diagnostic and treatment technologies. The United States, in particular, is a key market, with increasing investments in healthcare & rising awareness of gastrointestinal disease prevention and early detection.

Fastest-Growing Region: Asia-Pacific

The APAC region is the fastest-growing region in the gastroenterology market, with a CAGR of 7.1%. Countries such as China, Japan & India are witnessing rapid improvements in healthcare infrastructure, rising healthcare expenditure, and an increasing aging population, all contributing to the demand for gastroenterology services. Moreover, rising awareness about gastrointestinal diseases and expanding medical tourism for endoscopic procedures further fuel market growth in the region.

 

Gastroenterology Market Report Coverage

Report Attribute	Details
Forecast Period	2024 – 2032
Market Size Value in 2024	USD 36.3 Billion
Revenue Forecast in 2030	USD 52.1 Billion
Overall Growth Rate	CAGR of 6.2% (2024 – 2030)
Base Year for Estimation	2024
Historical Data	2017 – 2021
Unit	USD Billion, CAGR (2024 – 2030)
Segmentation	By Product Type, By Disease Type, By Procedure Type, By End-User, By Geography
By Product Type	Endoscopes; Endoscopic Ultrasound (EUS) Devices; Laparoscopes; Capsule Endoscopy Devices; Hemostasis Devices; Biopsy Forceps; Stents; Others
By Disease Type	Gastroesophageal Reflux Disease (GERD); Inflammatory Bowel Disease (IBD); Irritable Bowel Syndrome (IBS); Colorectal Cancer; Peptic Ulcer Disease; Liver Diseases; Others
By Procedure Type	Endoscopy; Colonoscopy; Laparoscopy; Esophagogastroduodenoscopy (EGD); Enteroscopy; Sigmoidoscopy; Others
By End-User	Hospitals; Ambulatory Surgical Centers (ASCs); Specialty Clinics; Diagnostic Centers
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Scope	US, Canada, Germany, China, India, etc.
Market Drivers	Rising prevalence of gastrointestinal diseases, advancements in endoscopic procedures, increasing demand for minimally invasive surgeries
Pricing and Purchase Options	Customized options available

 

Key Players in the Gastroenterology Market

• Olympus Corporation

• Medtronic plc

• Boston Scientific Corporation

• Fujifilm Holdings Corporation

• Cook Medical

• Pentax Medical (Hoya Corporation)

• STERIS plc

• Conmed Corporation

• Exact Sciences Corporation

• Becton, Dickinson and Company (BD).

 

Recent Developments

• In December 2024, PENTAX Medical, a division of HOYA Group, received U.S. FDA 510(k) clearance for new models of its i20c Video Endoscope Series, including the EC34-i20cL Video Colonoscope and the EG27-i20c Video Upper GI Scope. These endoscopes feature advanced imaging capabilities, enhanced maneuverability with adjustable stiffness, and improved ergonomics through the ErgoFeel control body and EasyOn connector. These design enhancements aim to improve procedural quality and optimize clinical workflows in gastrointestinal endoscopy.

• In April 2024, Medtronic introduced its latest artificial intelligence (AI) advancements in endoscopic care at the Genius Summit. The company launched ColonPRO software, designed to enhance the detection & diagnosis of colorectal conditions. Additionally, Medtronic announced a strategic collaboration with Modernizing Medicine to improve patient workflow efficiency, aiming to streamline endoscopic procedures & enhance patient outcomes.

• In June 2024, Boston Scientific expanded its stroke prevention device portfolio by acquiring Silk Road Medical for $1.6 billion. This strategic move aims to enhance Boston Scientific's offerings in the neurovascular space, potentially impacting related gastrointestinal procedures by broadening the company's comprehensive medical device portfolio.

 

Future Outlook

The future outlook for the gastroenterology market remains highly promising, driven by the rising prevalence of gastrointestinal (GI) disorders, increasing adoption of minimally invasive procedures & advancements in endoscopic technologies. Conditions such as colorectal cancer, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and gastroesophageal reflux disease (GERD) are becoming more widespread due to aging populations, sedentary lifestyles, and dietary changes. The demand for advanced diagnostic & therapeutic gastroenterology devices, including endoscopes, capsule endoscopy & robotic-assisted procedures, is expected to grow significantly. Additionally, biologic therapies, gut microbiome-based treatments, and precision medicine approaches are revolutionizing the management of GI diseases. North America & Europe are anticipated to dominate the market due to strong healthcare infrastructure & high awareness, while emerging economies in Asia-Pacific & Latin America will witness rapid growth owing to increased healthcare expenditure and improved access to diagnostics. However, challenges such as high procedure costs, stringent regulatory frameworks & reimbursement limitations may impact market expansion. Despite these challenges, continued technological innovation, rising investment in GI research, and the growing trend of outpatient endoscopic procedures will drive substantial market growth in the coming years.